Montek (Sodium Molybdate (99mo))

Sodium Molybdate, the active ingredient in Montek, is a trace‑element compound presented as an injectable solution for intravenous and ocular use. It is supplied for research, investigational or diagnostic purposes rather than a specific therapeutic indication. GNH USA supplies Montek as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Montek (sodium molybdate) is provided primarily for non‑therapeutic applications and investigational research. - No approved clinical indication: The product is not marketed for treatment of a specific disease. - Research use only: Utilized in laboratory studies of molybdenum metabolism and enzyme function. - Experimental diagnostic imaging: Explored as a contrast agent in ocular imaging studies.

Sodium molybdate may be associated with adverse reactions when administered intravenously or ocularly.

Common Side Effects: - Injection site pain: mild discomfort at the administration site. - Nausea: transient feeling of queasiness. - Headache: mild to moderate headache. - Transient visual disturbance: temporary changes in vision after ocular administration. - Mild flushing: temporary reddening of skin.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Hypotension: sudden drop in blood pressure. - Severe ocular inflammation: significant inflammation of the eye. - Renal impairment: reduced kidney function in susceptible individuals. - Hemolysis: destruction of red blood cells. - Thrombocytopenia: low platelet count.

When handling Montek, consider the following precautions: - Contraindication: Do not use in patients with known hypersensitivity to molybdenum compounds. - Pregnancy: Avoid use unless clearly needed; safety not established. - Breastfeeding: Use with caution; molybdenum may be excreted in milk. - Renal function: Monitor patients with impaired kidney function. - Drug interactions: Review concomitant use of other trace‑element supplements. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Potential drug interactions with sodium molybdate should be assessed.

Major Interactions (Avoid): - Copper supplements: may exacerbate copper deficiency. - High‑dose zinc: can interfere with molybdenum absorption. - Certain antibiotics (e.g., tetracyclines): may chelate molybdenum.

Moderate Interactions (Monitor Closely): - Vitamin B12: high doses may affect molybdenum metabolism. - Diuretics: may alter renal excretion of molybdenum. - Antacids containing aluminum or magnesium: could affect absorption.